Amyris is a synthetic biotechnology company focused on the Clean Health and Beauty markets. Co. applies its proprietary Lab-to-Market biotechnology platform to engineer, manufacture and market products. Co. does so with the use of computational tools, strain construction tools, screening and analytics tools, and lab automation and data integration. Co. produced a renewable farnesene brand, Biofene®, a long-chain, branched hydrocarbon molecule that Co. manufactures through fermentation using engineered microbes. Co.'s farnesene derivatives are sold in products as nutraceuticals, skincare products, fragrances, solvents, polymers, and lubricant ingredients. The AMRS stock yearly return is shown above.
The yearly return on the AMRS stock yearly return page and across the coverage universe of our site,
is a measure of the annual return over the calendar year 2017 for the given stock.
When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is
more than just the change in price if that instrument pays a dividend or coupon.
One way to factor dividends into the return is simply to count them as cash — we don't do
that here. Instead, our website aims to empower investors
by performing the AMRS annual return calculation with any dividends reinvested as applicable (on ex-dates).
|